GeneCopoeia Lentifect SARS-CoV-2 Spike-pseudotyped lentivirus
GeneCopoeia’s Lentifect SARS-CoV-2 Spike-pseudotyped lentivirus products are designed to produce a specially packaged variant of standard lentivirus that replaces VSV-G envelope glycoprotein with the Spike (S) protein.
The company’s spike-pseudotyped lentivirus can be used for several applications, such as: vaccine development for the SARS-CoV-2 virus; studying the efficacy and mechanism of neutralising antibodies against the SARS-CoV-2 virus; development of antiviral therapeutic agents; and studying the mechanism of virus-receptor interaction.
In addition to lentiviral particles, GeneCopoeia also offers a SARS-CoV-2 Spike Protein Pseudotyped Lentivirus Particle Kit that includes all required reagents: Lentifect SARS-CoV-2 Spike protein-pseudotyped lentiviral particles; Lentifect Standard VSV-G lentiviral particles; and the company’s ACE2-expressing HEK293T cell line.
For more information: https://www.genecopoeia.com/product/lentifect-sars-cov-2-spike-pseudotyped-lentivirus/.
Phone: 02 4575 0309
AlphaThera oYo-Link Antibody Labeling Reagents
AlphaThera's oYo-Link Antibody Labeling Reagents enable site-specific antibody labelling....
Bio-Rad Laboratories StarBright Red 715, 775 and 815 Dyes and expanded antibody markers
The StarBright Dyes — proprietary fluorescent nanoparticles conjugated to flow-validated...
RevMAb Biosciences histone family protein monoclonal antibodies
RevMAb Biosciences offers a wide range of recombinant monoclonal antibodies against histone...